Le Lézard
Classified in: Business
Subject: STR

Canadian Investment Regulatory Organization Trade Resumption - MNTR


VANCOUVER, BC, July 14, 2023 /CNW/ - Trading resumes in:

Company: Mantaro Precious Metals Corp. 

TSX-Venture Symbol: MNTR  

All Issues: Yes

Resumption (ET): 09:30 AM 

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) ? Halts/Resumptions


These press releases may also interest you

at 02:00
Caledonia Mining Corporation Plc ("Caledonia" or "the Company")  announces its operating and financial results for the quarter ended March 31, 2024 (the "Quarter"). Further information on the financial and operating results for the Quarter can be...

at 02:00
SAP SE today announced Charoen Pokphand Foods Public Company Limited ("CP Foods") has selected multiple SAP solutions to drive further growth and competitive advantage and to ensure the sustainability of its products for the future.  ...

at 01:45
Newgen Software, a global provider of a low-code platform for end-to-end automation at scale, announced that it has been named in the Gartner® Market Guide for Commercial Banking Cash Management and Trade Finance Solutions, 2023 report. Gartner...

at 01:30
XRP Healthcare, a pioneering force in healthcare innovation, proudly announces the registration of its trademark in Uganda, marking a significant milestone in its commitment to revolutionize healthcare services in the region. Concurrently, the...

at 01:29
On May 10, 2024, the BGI-Heilongjiang Omics Health Axis Intelligent Laboratory (BGI-HL OHA Intelligent Laboratory) was inaugurated in Harbin, Heilongjiang province, China, marking a significant advance in the province's efforts to address public...

at 01:20
Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results from the first quarter 2024. Almirall delivered strong sales growth in the first quarter of 2024 which continues to be driven by the...



News published on and distributed by: